Systematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent Immunizations

Journal of Adolescent Health

Volumn 59, Issue 2, 2016, Pages S40-S48

  Das, Jai K ^a   Salam, Rehana A ^a   Arshad, Ahmed ^a   Lassi, Zohra S ^b   Bhutta, Zulfiqar A ^a,c  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Adolescent health; Immunization; National permissive recommendation; National vaccination; Reminders; School vaccination; Vaccination

Indexed keywords

CHICKENPOX VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE; WART VIRUS VACCINE;

ADOLESCENT HEALTH; CHICKENPOX; CLINICAL EFFECTIVENESS; CONDYLOMA ACUMINATUM; DEATH; DISEASE PREDISPOSITION; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; INCIDENCE; MEASLES; MUMPS; PERTUSSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RUBELLA; UNITED STATES; VACCINATION; WART VIRUS;

EID: 84992482489     PISSN: 1054139X     EISSN: 18791972     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2016.07.005     Document Type: Review

References (54)

1. [1] National Foundation for Infectious Diseases: Adolescent vaccination bridging from a strong childhood foundation to a healthy adulthood: A report on strategies to increase adolescent immunization rates. Available at: http://www2.aap.org/immunization/pediatricians/pdf/ImmunizationofAdolescents_nfid.pdf. Accessed November 16, 2015.
2. [2] National Foundation of Infectious Diseases. Adolescent vaccination: Bridging from a strong childhood foundation to a healthy adulthood. 2012 Available at: https://www.aap.org/en-us/Documents/immunization_Adolescents_nfid.pdf Accessed November 16, 2015.
3. [3] Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013—United States. Morbidity Mortality Weekly Rep, 2013 Available at: http://www2.aap.org/immunization/illnesses/hpv/HPV2013MMWR.pdf Accessed November 16, 2015.
4. [4] Wong, C.A., Taylor, J.A., Wright, J.A., et al. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health 53 (2013), 492–497.
5. [5] World Health Organization. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide. 2012 Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx Accessed November 16, 2015.
6. [6] Forman, D., de Martel, C., Lacey, C.J., et al. Global burden of human papillomavirus and related diseases. Vaccine 30 (2012), F12–F23.
7. [7] WHO/ICO Information center on HPV and Cervical Cancer. Human papilomavirus and related cancers in Ethiopia. Summary report, 2010 Available at: www.hpvcentre.net Accessed November 16, 2015.
8. [8] Fitzmaurice, C., Dicker, D., Pain, A., et al. The global burden of cancer 2013. JAMA Oncol, 4, 2015, 505.
9. [9] Kessels, S.J.M., Marshall, H.S., Watson, M., et al. Factors associated with HPV vaccine uptake in teenage girls: A systematic review. Vaccine 30 (2012), 3546–3556.
10. [10] World Health Organization. WHO recommendations for routine immunization—Summary tables. 2015 Available at: http://www.who.int/immunization/policy/immunization_tables/en/ Accessed November 16, 2015.
11. [11] American Academy of Pediatrics Immunization Resources. Adolescent immunizations: Strategies for increasing coverage rates. 2013 Available at: http://www2.aap.org/immunization/pediatricians/pdf/TopStrategiesforIncreasingCoverage.pdf Accessed November 16, 2015.
12. [12] Salam, R.A., Faqqah, A., Sajjad, N., et al. Improving adolescent sexual and reproductive health: A systematic review of potential interventions. J Adolesc Health 59:Suppl. 4 (2016), S11–S28.
13. [13] Salam, R.A., Hooda, M., Das, J.K., et al. Interventions to improve adolescent nutrition: A systematic review and meta-analysis. J Adolesc Health 59:Suppl. 4 (2016), S29–S39.
14. [14] Das, J.K., Salam, R.A., Arshad, A., et al. Interventions for adolescent substance abuse: An overview of systematic reviews. J Adolesc Health 59:Suppl. 4 (2016), S61–S75.
15. [15] Das, J.K., Salam, R.A., Lassi, Z.S., et al. Interventions for adolescent mental health: an overview of systematic reviews. J Adolesc Health 59:Suppl. 4 (2016), S49–S60.
16. [16] Salam, R.A., Arshad, A., Das, J.K., et al. Interventions to prevent unintentional injuries among adolescents: A systematic review and meta-analysis. J Adolesc Health 59:Suppl. 4 (2016), S76–S87.
17. [17] Salam, R.A., Das, J.K., Lassi, Z.S., Bhutta, Z.A., Adolescent health interventions: Conclusions, evidence gaps, and research priorities. J Adolesc Health 59:Suppl. 4 (2016), S88–S92.
18. [18] Salam, R.A., Das, J.K., Lassi, Z.S., Bhutta, Z.A., Adolescent health and well-being: Background and methodology for review of potential interventions. J Adolesc Health 59:Suppl. 4 (2016), S4–S10.
19. [19] Centers for Disease Control and Prevention. Vaccine recommendations of the ACIP. 2014 Available at: http://www.cdc.gov/vaccines/hcp/acip-recs/index.html Accessed November 16, 2015.
20. [20] Walker, N., Fischer-Walker, C., Bryce, J., et al. Standards for CHERG reviews of intervention effects on child survival. Int J Epidemiol 39:Suppl. 1 (2010), i21–i31.
21. [21] Zhuo, J., Geng, W., Hoekstra, E.J., et al. Impact of supplementary immunization activities in measles-endemic areas: A case study from Guangxi, China. J Infect Dis 204:Suppl. 1 (2011), S455–S462.
22. [22] Ogbuanu, I.U., Kutty, P.K., Hudson, J.M., et al. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak. Pediatrics 130 (2012), e1567–e1574.
23. [23] Nguyen, H.Q., Jumaan, A.O., Seward, J.F., Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352 (2005), 450–458.
24. [24] Quinn, H.E., McIntyre, P.B., The impact of adolescent pertussis immunization, 2004-2009: Lessons from Australia. Bull World Health Organ 89 (2011), 666–674.
25. [25] Nelson, D.B., Layde, M.M., Chatton, T.B., Rubella susceptibility in inner-city adolescents: The effect of a school immunization law. Am J Public Health 72 (1982), 710–713.
26. [26] Baandrup, L., Blomberg, M., Dehlendorff, C., et al. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis 40 (2013), 130–135.
27. [27] Bauer, H.M., Wright, G., Chow, J., Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: An analysis of California public family planning administrative claims data, 2007-2010. Am J Public Health 102 (2012), 833–835.
28. [28] Markowitz, L.E., Hariri, S., Lin, C., et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 208 (2013), 385–393.
29. [29] Mesher, D., Soldan, K., Howell-Jones, R., et al. Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England. Vaccine 32 (2013), 26–32.
30. [30] Musto, R., Siever, J.E., Johnston, J.C., et al. Social equity in human papillomavirus vaccination: A natural experiment in Calgary Canada. BMC Public Health, 13, 2013, 640.
31. [31] Read, T.R., Hocking, J.S., Chen, M.Y., et al. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87 (2011), 544–547.
32. [32] Reiter, P.L., Gilkey, M.B., Brewer, N.T., HPV vaccination among adolescent males: Results from the National Immunization Survey-Teen. Vaccine 31 (2013), 2816–2821.
33. [33] Averhoff, F., Linton, L., Peddecord, K.M., et al. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health 94 (2004), 978–984.
34. [34] Bugenske, E., Stokley, S., Kennedy, A., Dorell, C., Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics 129 (2012), 1056–1063.
35. [35] Carlson, J.A., Lewis, C.A., Effect of the immunization program in Ontario schools. Can Med Assoc J 133 (1985), 215–216.
36. [36] Fogarty, K.J., Massoudi, M.S., Gallo, W., et al. Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000. Public Health Rep 119 (2004), 163–169.
37. [37] Harper, P.G., Murray, D.M., An organizational strategy to improve adolescent measles-mumps-rubella vaccination in a low socioeconomic population. A method to reduce missed opportunities. Arch Fam Med 3 (1994), 257–262.
38. [38] Kempe, A., Barrow, J., Stokley, S., et al. Effectiveness and cost of immunization recall at school-based health centers. Pediatrics 129 (2012), e1446–e1452.
39. [39] Kharbanda, E.O., Stockwell, M.S., Colgrove, J., et al. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Am J Public Health 100 (2010), 1635–1640.
40. [40] Moss, J.L., Reiter, P.L., Dayton, A., Brewer, N.T., Increasing adolescent immunization by webinar: A brief provider intervention at federally qualified health centers. Vaccine 30 (2012), 4960–4963.
41. [41] Stockwell, M.S., Kharbanda, E.O., Martinez, R.A., et al. Text4Health: Impact of text message reminder-recalls for pediatric and adolescent immunizations. Am J Public Health 102 (2012), e15–e21.
42. [42] Suh, C.A., Saville, A., Daley, M.F., et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 129 (2012), e1437–e1445.
43. [43] Szilagyi, P.G., Albertin, C., Humiston, S.G., et al. A randomized trial of the effect of centralized reminder/recall on immunizations and preventive care visits for adolescents. Acad Pediatr 13 (2013), 204–213.
44. [44] World Health Organization. Immunization, vaccines and biologicals: Data, statistics and graphics. 2015 Available at: http://www.who.int/immunization/monitoring_surveillance/data/en/ Accessed November 16, 2015.
45. [45] World Health Organization. Immunization, vaccines and biologicals: School-based immunization. 2015 Available at: http://www.who.int/immunization/programmes_systems/policies_strategies/school_based_immunization/en/ Accessed November 16, 2015.
46. [46] Adams, P., Reaching teenagers with three-times jab is a first for most countries. World Health Organization Bull World Health Organ, 90, 2012, 874.
47. [47] Binagwaho, A., Wagner, C.M., Gatera, M., et al. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 90 (2012), 623–628.
48. [48] Holman, D.M., Benar, V., Roland, K.B., et al. Barriers to human papillomavirus vaccination among US Adolescents. A systematic review of the literature. JAMA Pediatr 168 (2014), 76–82.
49. [49] Cassidy, B., Elizabeth, A.S., Uptake of the human papillomavirus vaccine: A review of the literature and report of a quality assurance project. J Pediatr Health Care 26 (2012), 92–101.
50. [50] Middleman, A.B., Rosenthal, S.L., Rickert, V.I., et al. Adolescent immunizations: A position paper of the Society for Adolescent Medicine. J Adolesc Health 38 (2006), 321–327.
51. [51] Tissot, A.M., Zimet, G.D., Rosenthal, S.L., et al. Effective strategies for HPV vaccine delivery: The views of pediatricians. J Adolesc Health 41 (2007), 119–125.
52. [52] John D Piette a, KC Lun b, Lincoln A Moura c, Hamish SF Fraser d, Patricia N Mechael e, John Powell f & Shariq R Khoja g. Impacts of e-health on the outcomes of care in low- and middle-income countries: Where do we go from here? Bulletin of the World Health Organization. Available at: http://www.who.int/bulletin/volumes/90/5/11-099069/en/index.html. Accessed November 16, 2015.
53. [53] Jit, M., Brisson, M., Portnoy, A., Hutubessy, R., Cost-effectiveness of female human papillomavirus vaccination in 179 countries: A PRIME modelling study. The Lancet Glob Health 2 (2014), e406–e414.
54. [54] Fesenfeld, M., Hutubessy, R., Jit, M., Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: A systematic review. Vaccine 31 (2013), 3786–3804.